Are you Dr. Mulvihill?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1200 N Phillips Ave
Suite 5100
Oklahoma City, OK 73104Phone+1 405-271-2006Fax+1 405-271-2263
Summary
- Dr. John Mulvihill, MD is a board certified medical geneticist in Oklahoma City, Oklahoma. He is currently licensed to practice medicine in Oklahoma, Pennsylvania, and Maryland. He is affiliated with OU Health, Oklahoma Children’s Hospital OU Health, and Oklahoma City VA Medical Center.
Education & Training
- Johns Hopkins UniversityResidency, Pediatrics, 1972 - 1974
- University of Washington School of MedicineInternship, Transitional Year, 1969 - 1970
- University of Washington School of MedicineClass of 1969
Certifications & Licensure
- OK State Medical License 1998 - 2022
- PA State Medical License 1990 - 2022
- MD State Medical License 1972 - 1991
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Fetal Alcohol Syndrome/ARND Research Consortion Start of enrollment: 2001 Oct 01
Publications & Presentations
PubMed
- 565 citationsStudy design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project.Leslie L. Robison, Ann C. Mertens, John D. Boice, Norman E. Breslow, Sarah S. Donaldson
Medical and Pediatric Oncology. 2002-04-01 - 493 citationsThe Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention ResearchLeslie L. Robison, Gregory T. Armstrong, John D. Boice, Eric J. Chow, Stella M. Davies
Journal of Clinical Oncology. 2009-05-10 - 223 citationsEffect of Genetic Diagnosis on Patients with Previously Undiagnosed DiseaseKimberly Splinter, David R. Adams, Carlos A. Bacino, Hugo J. Bellen, Jonathan A. Bernstein
The New England Journal of Medicine. 2018-10-10
Press Mentions
- Mechanical, Compositional and Morphological Characterisation of the Human Male Urethra for the Development of a Biomimetic Tissue Engineered Urethral ScaffoldJanuary 9th, 2021
- Meet Robert, the Father of Drug Delivery and Tissue EngineeringJune 20th, 2017
Professional Memberships
- Fellow